Global Clinical Trial Supplies Market Size study, by Service (Logistics & distribution, Storage & retention, Packaging, labeling, and blinding, Manufacturing, Comparator sourcing, Other services), by End-Use (Pharmaceutical & Biotechnology companies, Cont

Global Clinical Trial Supplies Market Size study, by Service (Logistics & distribution, Storage & retention, Packaging, labeling, and blinding, Manufacturing, Comparator sourcing, Other services), by End-Use (Pharmaceutical & Biotechnology companies, Contract Research Organisations (CROs), Medical Devices Companies) and Regional Forecasts 2022-2028

Global Clinical Trial Supplies Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Clinical Supply, or Clinical Trial Supply, is defined as the supply of materials required for conducting a clinical trial and this includes 24-hour collection and delivery of biological specimens (including infectious samples), investigational drugs, kits and other study materials and supplies, expert assistance. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies and increasing number of registered clinical trials has led to the adoption of Clinical Trial Supplies across the forecast period. For Instance: As per the IBEF, India’s medical devices market stood at US$ 10.36 billion in FY20. The market is expected to increase at a CAGR of 37% from 2020 to 2025 to reach US$ 50 billion. Also, with the increasing emerging markets, the adoption & demand for Clinical Trial Supplies is likely to increase the market growth during the forecast period. However, high cost of drug development impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Clinical Trial Supplies market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to the growing number of registered clinical trials and significant investments in R&D for clinical trials in this region. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as rising disposable income, rising incidences of injuries and high incidence and prevalence of cancer would create lucrative growth prospects for the Clinical Trial Supplies market across Asia-Pacific region.

Major market players included in this report are:
Biocair (UK)
Thermo Fisher (US)
Catalent, Inc. (US)
Parexel (US)
Eurofins (France)
UDG Healthcare (Ireland)
Piramal Pharma Solutions (India)
Almac Group (UK)
PCI Pharma Services (US)
PRA Health Sciences (US)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Service:
Logistics & distribution
Storage & retention
Packaging, labeling, and blinding
Manufacturing
Comparator sourcing
Other services
By End-Use:
Pharmaceutical & Biotechnology companies
Contract Research Organisations (CROs)
Medical Devices Companies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Clinical Trial Supplies Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Biocair (UK)
Thermo Fisher (US)
Catalent, Inc. (US)
Parexel (US)
Eurofins (France)
UDG Healthcare (Ireland)
Piramal Pharma Solutions (India)
Almac Group (UK)
PCI Pharma Services (US)
PRA Health Sciences (US)

Please note:The single user license is non-downloadable and non-printable. Global Site license will allow these actions.